Mariluz Soula

1.2k citations
8 papers · 670 indexed · 1 hit paper · h-index 6

Mariluz Soula

8 papers receiving 663 citations

Hit Papers

Metabolic determinants of cancer cell sensitivity to cano...5382020202620222024100200300400500

Peers

Mariluz Soula
Comparison fields: 5 of 68
  • Cancer Research 359
  • Pulmonary and Respiratory Medicine 438
  • Molecular Biology 437
  • Biochemistry 22
  • Oncology 69
Replace Macus Hao‐Ran Bao with:
Macus Hao‐Ran Bao Hong Kong
Zhixuan Bian China
Céline Guilbaud Belgium
Emeline Dierge Belgium
Anna Budina-Kolomets United States
Yadong Sun China
Zuli Wang China
Wenhua Gao United States
Benxin Hou China
Lingming Kong China
Mariluz Soula relative to Macus Hao‐Ran Bao Hong Kong Macus Hao‐Ran Bao's profile →
Citations per field
00.5×2.5×
Macus Hao‐Ran Bao · 1×
Citations per year

Countries citing papers authored by Mariluz Soula

Since Specialization
Citations

This map shows the geographic impact of Mariluz Soula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariluz Soula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariluz Soula more than expected).

Fields of papers citing papers by Mariluz Soula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariluz Soula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariluz Soula. The network helps show where Mariluz Soula may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mariluz Soula, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mariluz Soula Line = papers co-authored together Mariluz Soula links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 202432
2 202236
3 20211
4
Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducersbreakdown →
2020538
5 201926
6 20191
7 201718
8 201718

About Mariluz Soula

Mariluz Soula is a scholar working on Clinical Biochemistry, Public Health, Environmental and Occupational Health and Cancer Research, having authored 8 papers that have together received 670 indexed citations. Recurring topics across this work include Pregnancy-related medical research (4 papers), Immune cells in cancer (2 papers), Cancer, Lipids, and Metabolism (1 paper), RNA modifications and cancer (1 paper), Glycosylation and Glycoproteins Research (1 paper), Cellular transport and secretion (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (359 citations), Pulmonary and Respiratory Medicine (438 citations) and Molecular Biology (437 citations). Mariluz Soula has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Hanan Alwaseem, Kıvanç Birsoy, Konnor La, Henrik Molina, Javier García‐Bermúdez, Omkar Zilka, Ross Weber, Derek A. Pratt, Manija A. Kazmi and Thomas P. Sakmar. Their work appears in journals such as Nature, Journal of Biological Chemistry and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026